← All organizations

Carmell Therapeutics

For profitWebsite ↗

Also known as: Carmell Therapeutics | Carmell Therapeutics Corporation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 31, 2024

Timeline

2000s

Jan 1, 2007
Carmell Therapeutics— Founded

2020s

Sep 12, 2023
Axolotl Biologix— Acquired

Drugs by trial phase (2 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

calcium phosphate

Phase 2 (0 own, 1 via acquisition)

axolotl ambient

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Axolotl Biologix

Recent trials (5)

NCT06258499Lead sponsorPhase 2Mar 31, 2024
NCT04056429Lead sponsorPhase 3Dec 31, 2019
NCT04056429Study directorPhase 3Dec 31, 2019
NCT03826784Lead sponsorPhase 3Jun 30, 2019
NCT03826784Study directorPhase 3Jun 30, 2019

Details

Founded: Pittsburgh, PA, US Jan 1, 2007
Last known activity: Mar 31, 2024